The Food and Drug Administration (FDA) recently approved a new sunscreen ingredient for U.S. markets. While this may seem routine, it marks the first such approval since 1999. The delay stems from an 88-year-old law.
The original legislation, from 1938, aimed to regulate the safety and efficacy of all drugs, including over-the-counter products like sunscreens. However, this means that new sunscreen components have faced significant hurdles before reaching consumers, despite advancements in skincare elsewhere.
Many countries have swiftly adopted innovative sunscreen formulas, offering people better protection against harmful UV rays. Meanwhile, Americans have had to wait for decades to benefit from these advancements.
The recent approval, however, shines a light on the outdated regulatory framework that has long restricted U.S. consumer access. The FDA’s move could signify a shift towards allowing safer and more effective sun protection options for Americans.
As skin cancer remains a significant health issue, expedited access to advanced sunscreens could enhance public health. The change also highlights the importance of continuous evaluation and modernization of existing health regulations.
Cancer Death Rates Decline in the U.S., But Disparities Remain 
Rising Heat Poses Threat Across U.S., Authorities Warn 
COVID-19 Vaccine Study Highlights Effectiveness Amid Controversy 
Life Inside Biocontainment and Updates on Covid-19 Vaccine Policies 
Extreme Heat Risk Spreads Across the U.S. 
Efforts to Address Hospice Fraud and Strengthen Program Integrity